the abcellera biologics ( acc ) company is a new and promising industry industry that is a major frontier in the field of drug discovery. we have developed a unique business model that can accelerate drug discovery across the industry. we have developed a unique business model that can be used to accelerate drug discovery across the industry. we have developed a unique business model that can be used to accelerate drug discovery across the industry. we have developed a unique business model that can be used to accelerate drug discovery across the industry. we have successfully successfully acquired the orthomab platform for bispecific antibodies and a bispecific engineering platform. we have successfully acquired trianni and also made significant investments in facilities and equipment to strengthen our teams and technology platform. we are now in a strong liquidity position, which will allow us to continue to build capacity and expand platform capabilities and pursue the business development initiatives.